Longitudinal decline in lung function: Evaluation of interleukin-10 genetic polymorphisms in firefighters

Journal of Occupational and Environmental Medicine

Volumn 46, Issue 10, 2004, Pages 1013-1022

  Burgess, Jefferey L ^a   Fierro, Maria A ^a   Lantz, R Clark ^a   Hysong, Tracy A ^a   Fleming, Joy E ^a   Gerkin, Richard ^b   Hnizdo, Eva ^c   Conley, Shannon M ^a   Klimecki, Walter ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; INTERLEUKIN 10;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DETERIORATION; DISEASE PREDISPOSITION; FEMALE; FIRE FIGHTER; FORCED EXPIRATORY VOLUME; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; LUNG FUNCTION; MALE; NORMAL HUMAN; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADULT; ANALYSIS OF VARIANCE; BASE SEQUENCE; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FIRES; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; GENETIC MARKERS; HUMANS; INCIDENCE; INTERLEUKIN-10; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OCCUPATIONAL DISEASES; OCCUPATIONAL HEALTH; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROBABILITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT;

EID: 5444250300     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000141668.70006.52     Document Type: Article

References (64)

1. Bloom JW, Sugihara S, Garfield MD, Abraham TA, Knudson RJ. Characteristics of individuals with accelerated declines in lung function. Chest. 1985;6:18S-19S.
2. Burchfiel CM, Marcus EB, Sharp DS, et al. Characteristics associated with rapid decline in forced expiratory volumes. Ann Epidemiol. 1996;6:217-227.
3. Burrows B, Lebowitz MD, Camilli AE, Rnudson RJ. Longitudinal changes in forced expiratory volume in one second in adults. Methodologic considerations and findings in healthy nonsmokers. Am Rev Respir Dis. 1986;133:974-980.
4. Burgess JL, Nanson CJ, Bolstad-Johnson DM, et al. Adverse respiratory effects following overhaul in firefighters. J Occup Environ Med. 2001;43:467-473.
5. Burgess JL, Brodkin CA, Daniell WE, et al. Longitudinal decline in firefighters DLCO measurements: a respiratory surveillance dilemma. Am J Respir Crit Care Med. 1999;159:119-124.
6. Tepper A, Comstock GW, Levine M. A longitudinal study of pulmonary function in fire fighters. Am J Ind Med. 1991;20: 307-316.
7. Horsfield K, Guyatt AR, Cooper FM, Buckman M, Cumming M. Lung function in west Sussex firemen: a four year study. Br J Ind Med. 1988;45:116-121.
8. Burgess JL, Witten ML, Nanson CJ, et al. Serum pneumoproteins: a cross-sectional comparison of firefighters and police. Am J Ind Med. 2003;44:246-253.
9. Hertzberg VS, Rosenman KD, Reilly MJ, Rice CH. Effect of occupational silica exposure on pulmonary function. Chest. 2002;122:721-728.
10. Kirychuk S, Senthilselvan A, Dosman JA, et al. Predictors of longitudinal changes in pulmonary function among swine confinement workers. Can Respir J. 1998;5:472-478.
11. Wang XR, Pan LD, Zhang HX, Sun BX. Dai HL, Christiani DC. Follow-up study of respiratory health of newly-hired female cotton textile workers. Am J Ind Med. 2002;41:111-118.
12. Carey IM, Cook DG, Strachan DP. The effects of adiposity and weight change on forced expiratory volume decline in a longitudinal study of adults. Int J Obes Relat Metab Disord. 1999;23:979-985.
13. Banks DE, Shah AA, Lopez M, Wang ML. Chest illnesses and the decline of FEV1 in steel workers. J Occup Environ Med. 1999;41:1085-1090.
14. Laurell CB, Eriksson S. The electrophoretic α1-globulin pattern of serum of α1-antitrypson deficiency. Scand J Clin Lab Invest. 1963;15:132-140.
15. Bidani A, Wang CZ, Heming TA. Early effects of smoke inhalation on alveolar macrophage functions. Burns. 1996;22: 101-106.
16. Witten ML, Lantz RC, Grad R, et al. Effect of smoke inhalation on immediate changes in lung chemical mediators. Res Commun Chem Pathol Pharmacol. 1991; 74:259-272.
17. Riyami BM, Kinsella J, Pollok AJ, et al. Alveolar macrophage chemotaxis in fire victims with smoke inhalation and burns injury. Eur J Clin Invest. 1991;21:485-489.
18. Tockman MS, Pearson JD, Fleg JL, et al. Rapid decline in FEV1. A new risk factor for coronary heart disease mortality. Am J Respir Crit Care Med. 1995;151:390-398.
19. De Waal Malefyt R, Moore KW. Interleukin-10. In: Thomson AW. The Cytokine Handbook. 3rd ed. San Diego: Academic Press; 1998:333-364.
20. Busiek DF, Baragi V, Nehring LC, Parks WC, Welgus HG. Matrilysin Expression by human mononuclear phagocytes and its regulation by cytokines and hormones. J Immunol. 1995;154:6484-6491.
21. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest. 1995;96: 2304-2310.
22. Stearns ME, Rhim J, and Wang M. Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion. Clin Cancer Res. 1999;5:189-196.
23. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996;153: 530-534.
24. Takanashi S, Hasegawa Y, Kanehira Y, et al. 1999. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur Respir J. 1999;14:309-314.
25. Burgess JL, Nanson CJ, Gerkin R, Witten ML, Hysong TA, Lantz RC. Rapid decline in sputum IL-10 concentration following occupational smoke exposure. Inhal Toxicol. 2002;14:133-140.
26. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1-8.
27. Kube D, Platzer C, von Knethen A, et al. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine. 1995;7:1-7.
28. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum. 1999;42: 1101-8.
29. Lazarus R, Klimecki WT, Palmer LJ, et al. Single-nucleotide polymorphisms in the interleukin-10 gene: differences in frequencies, linkage disequilibrium patterns, and haplotypes in three United States ethnic groups. Genomics. 2002;80:223-228.
30. Lahiri DK, Nurnberger JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19:5444, 1991.
31. Douglas DB, Douglas RB, Oakes D, Scott G. Pulmonary function of London firemen. Br J Ind Med. 1985;42:55-58.
32. Musk AW, Peters JM, Wegman DW. Lung function in firefighters, I: a three year follow-up of active subjects. Am J Public Health. 1977;67:626-629.
33. Musk AW, Peters JM, Bernstein L, Rubin C, Monroe CB. Lung function in firefighters: a six-year follow up in the Boston fire department. Am J Ind Med. 1982;3:3-9.
34. Peters JM, Theriault GP, Fine LJ, Wegman DH. Chronic effect of fire fighting on pulmonary function. N Engl J Med. 1974;291:1320-1322.
35. Sparrow D, Bosse R, Rosner B, Weiss ST. The effect of occupational exposure on pulmonary function. Am Rev Respir Dis. 1982;125:319-322.
36. Ware JH, Dockery DW, Louis TA, Xu XP, Ferris BG, Speizer FE. Longitudinal and cross-sectional estimates of pulmonary function decline in never-smoking adults. Am J Epidemiol. 1990;132:685-700.
37. Xu X, Dockery DW, Ware JH, Speizer FE, Ferris BG. Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. Am Rev Respir Dis. 1992;146:1345-1348.
38. Meyer KC, Rosenthal NS, Soergel P, Peterson K. Neutrophils and low-grade inflammation in the seemingly normal aging human lung. Mech Ageing Dev. 1998;101:169-181.
39. Dockery DW, Ware JH, Ferris BG, et al. Distribution of forced expiratory volume in one second and forced vital capacity in healthy, white, adult never-smokers in six U.S. cities. Am Rev Respir Dis. 1985;131:511-520.
40. Vollmer WM, Johnson LR, McCamant LE, Buist AS. Methodologic issues in the analysis of lung function data. J Chronic Dis. 1987;40:1013-1023.
41. Silva GE, Sherrill DL, Guerra S, Barbee RA. A longitudinal study of alpha1-antitrypsin phenotypes and decline in FEV1 in a community population. Chest. 2003;123:1435-1440.
42. Peat JK, Woolcock AJ, Cullen K. Decline of lung function and development of chronic airflow limitation: a longitudinal study of non-smokers and smokers in Busselton, Western Australia. Thorax. 1990;45:32-37.
43. Burchfiel CM, Marcus EB, Curb JD, et al. Effects of smoking and smoking cessation on longitudinal decline in pulmonary function. Am J Respir Crit Care Med. 1995;151:1778-1785.
44. Camilli AE, Burrows B, Knudson RJ, Lyle SK, Lebowitz MD. Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. Am Rev Respir Dis. 1987;135:794-799.
45. Bosse R, Sparrow D, Rose CL, Weiss ST. Longitudinal effect of age and smoking cessation on pulmonary function. Am Rev Respir Dis. 1981;123:378-381.
46. Lio D, Licastro F, Scola L, et al. Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease. Genes Immun. 2003;4:234-238.
47. Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol. 2001;166:3915-3922.
48. Gallagher PM, Lowe G, Fitzgerald T, et al. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax. 2003;58:154-156.
49. Karjalainen J, Hulkkonen J, Nieminen MM, et al. Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma. Clin Exp Allergy. 2003;33:78-83.
50. Helminen ME, Kilpinen S, Virta M, Hurme M. Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J Infect Dis. 2001;184:777-780.
51. Rees LE, Wood NA, Gillespie KM, Lai KN, Gaston K, Mathieson PW. The interleukin-10-1082 G/A polymorphism: allele frequency in diferent populations and functional significance. Cell Mol Life Sci. 2002;59:560-569.
52. Zhang J, Chen H, Hu L, Fu J, Zhang H, Chen Y. Correlation between polymorphism of IL-4 and IL-10 gene promoter and childhood asthma and their impact upon cytokine expression. Chung-Hua i Hsueh Tsa Chih [Chinese Med J]. 2002; 82:114-118.
53. Cartwright NH, Keen LJ, Demaine AG, et al. A study of cytokine gene polymorphisms and protein secretion in renal transplantation. Transpl Immunol. 2001; 8:237-244.
54. Roh JW, Kim MH, Seo SS, Kang SB. Lee HP. Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women. Cancer Lett. 2002;184:57-63.
55. Nadif R, Jedlicka A, Mintz M, Bertrand JP, Kleeberger S, Kauffmann F. Effect of TNF and LTA polymorphisms on biological markers of response to oxidative stimuli in coal miners: a model of gene-environment interaction. Tumour necrosis factor and lymphotoxin alpha. J Med Genet. 2003;40:96-103.
56. Chinn DJ, Stevenson IC, Cotes JE. Longitudinal respiratory survey of shipyard workers: effects of trade and atopic status. Br J Ind Med. 1990;47:83-90.
57. Senthilselvan A, Dosman JA, Kirychuk SP, et al. Accelerated lung function decline in swine confinement workers. Chest. 1997;111:1733-1741.
58. Weiss ST, O'Connor GT, DeMolles D, Platts-Mills T, Sparrow D. Indoor allergens and longitudinal FEV1 decline in older adults: the Normative Aging Study. J Allergy Clin Immunol. 1998;101:720-725.
59. Wang ML, McCabe L, Hankinson JL, et al. Longitudinal and cross-sectional analyses of lung function in steelworkers. Am J Respir Crit Care Med. 1996;153: 1907-1913.
60. Wang ML, McCabe L, Petsonk EL, Hankinson JL, Banks DE. Weight gain and longitudinal changes in lung function in steel workers. Chest. 1997;111:1526-1532.
61. Mauny F, Polio JC, Monnet E, et al. Longitudinal study of respiratory health in dairy farmers: influence of artificial barn fodder drying. Eur Respir J. 1997; 10:2522-2528.
62. Sherrill D, Guerra S, Bobadilla A, Barbee R. The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics. Eur Respir J. 2003;21:95-100.
63. Ulrik CS, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med. 1994;150: 629-634.
64. Ulrik CS, Backer V, Dirksen A. Mortality and decline in lung function in 213 adults with bronchial asthma: a ten-year follow up. J Asthma. 1992;29:29-38.